Literature DB >> 21769009

Low vitamin d status of patients in methadone maintenance treatment.

Theresa W Kim1, Daniel P Alford, Michael F Holick, Alan O Malabanan, Jeffrey H Samet.   

Abstract

AIM: : To examine the prevalence and risk factors of low vitamin D status (vitamin D deficiency or insufficiency) among patients in a methadone maintenance treatment (MMT) program.
DESIGN: : Cross-sectional study of subjects recruited from an MMT program in a higher latitude (Boston, MA). MEASUREMENTS: : Standardized survey and medical record review were used to assess patient characteristics. Serum was tested to determine vitamin D deficiency (25-hydroxyvitamin D <20 ng/mL) and insufficiency (25-hydroxyvitamin D between 20 and 30 ng/mL). Multivariable analyses were used to assess risk factors associated with vitamin D deficiency.
FINDINGS: : Low vitamin D status was found in 52% of the subjects (48 of 93), deficiency in 36%, and insufficiency in an additional 16%. Older age (OR = 3.47; 95% CI 1.31-9.22) and black or Hispanic race/ethnicity (OR 3.34; 95% CI 1.30-8.58) were significantly associated with higher risk of vitamin D deficiency.
CONCLUSION: : Low vitamin D status was present in a majority of patients recruited from an MMT program. This raises the question as to whether this is a generalizable phenomenon and whether these patients are at higher risk of complications of low vitamin D status including bone pain, periodontal disease, osteomalacia, and cardiovascular disease.

Entities:  

Year:  2009        PMID: 21769009      PMCID: PMC4059827          DOI: 10.1097/ADM.0b013e31819b736d

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  39 in total

1.  Vitamin D insufficiency among free-living healthy young adults.

Authors:  Vin Tangpricha; Elizabeth N Pearce; Tai C Chen; Michael F Holick
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 3.  Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers.

Authors:  Michael F Holick
Journal:  South Med J       Date:  2005-10       Impact factor: 0.954

4.  Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.

Authors:  Astrid Fahrleitner; Harald Dobnig; Andrea Obernosterer; Ernst Pilger; Georg Leb; Kurt Weber; Stefan Kudlacek; Barbara M Obermayer-Pietsch
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

5.  Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities.

Authors:  Andrew Rosenblum; Herman Joseph; Chunki Fong; Steven Kipnis; Charles Cleland; Russell K Portenoy
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

6.  HIV infection and bone mineral density in middle-aged women.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Nanette Santoro; Ellie E Schoenbaum
Journal:  Clin Infect Dis       Date:  2006-02-24       Impact factor: 9.079

7.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Shanna Nesby-O'Dell; Kelley S Scanlon; Mary E Cogswell; Cathleen Gillespie; Bruce W Hollis; Anne C Looker; Chris Allen; Cindy Doughertly; Elaine W Gunter; Barbara A Bowman
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

8.  Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy.

Authors:  Jeffrey R Curtis; Barbara Smith; Michael Weaver; Kathleen Landers; Robert Lopez-Ben; James L Raper; Michael Saag; Rajesh Venkataraman; Kenneth G Saag
Journal:  AIDS Res Hum Retroviruses       Date:  2006-02       Impact factor: 2.205

9.  Persistent pain is associated with substance use after detoxification: a prospective cohort analysis.

Authors:  Mary Jo Larson; Michael Paasche-Orlow; Debbie M Cheng; Christine Lloyd-Travaglini; Richard Saitz; Jeffrey H Samet
Journal:  Addiction       Date:  2007-05       Impact factor: 6.526

10.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D.

Authors:  Michael F Holick; Rachael M Biancuzzo; Tai C Chen; Ellen K Klein; Azzie Young; Douglass Bibuld; Richard Reitz; Wael Salameh; Allen Ameri; Andrew D Tannenbaum
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

View more
  4 in total

1.  Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998-2006.

Authors:  Behnam Sharif; Bohdan Nosyk; Huiying Sun; David C Marsh; Aslam Anis
Journal:  Subst Use Misuse       Date:  2013-06-10       Impact factor: 2.164

2.  Genome-Wide Association Study of Opioid Cessation.

Authors:  Jiayi W Cox; Richard M Sherva; Kathryn L Lunetta; Emma C Johnson; Nicholas G Martin; Louisa Degenhardt; Arpana Agrawal; Elliot C Nelson; Henry R Kranzler; Joel Gelernter; Lindsay A Farrer
Journal:  J Clin Med       Date:  2020-01-09       Impact factor: 4.241

3.  Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway.

Authors:  Mitra Bemanian; Ranadip Chowdhury; Krister Stokke; Christer Frode Aas; Kjell Arne Johansson; Jørn Henrik Vold; Lars Thore Fadnes
Journal:  Sci Rep       Date:  2022-08-11       Impact factor: 4.996

Review 4.  Vitamin D and Its Potential Interplay With Pain Signaling Pathways.

Authors:  Abdella M Habib; Karim Nagi; Nagendra Babu Thillaiappan; VijayaKumar Sukumaran; Saghir Akhtar
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.